Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with VOR: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
VOR
Vor Biopharma Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
VOR
Vor Biopharma Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
AMGN
Amgen Inc
Change
478.34
· pre 482.52
· delayed
Mkt cap
$258.8B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
VOR
Vor Biopharma Inc.
Change
19.94
· pre 20.40
· delayed
Pre-market
Nov 5 '26
delayed
Mkt cap
$1.2B
Revenue
—
Revenue
—
vs
Compare
Pre-market
Nov 5 '26
delayed
AMGN
Amgen Inc
vs
VOR
Vor Biopharma Inc.
478.34
pre 482.52
delayed
Price
19.94
pre 20.40
delayed
$258.8B
Mkt cap
$1.2B
Q3 FY26
$10.4B
Revenue
—
FY25
$36.8B
Revenue
—
Change
Change
AMGN
478.34
vs
VOR
19.94
Pre-market
Nov 5 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
VOR: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No shared counterparties.
Only VOR
3
—
RemeGen
unlisted
supplier
—
The Trustees of Columbia University in the City of New York
unlisted
customer
—
U.S. Department of Health and Human Services, as represented by National Cancer Institute of the National Institutes of Health
unlisted
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
customer
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AMGN, solid
VOR, dashed